Drug Topics

NOVEMBER 7, 2022

Cannabinoids lack the habit-forming mechanism of action found in methadone and buprenorphine, unlocking new potential for the drug.

530

530

PhRMA

NOVEMBER 7, 2022

Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important decisions about patient access to health care based on their determination of the value of new tests and treatments. It’s important to consider the best available information and evidence when making health care decisions.

280

280

Drug Topics

NOVEMBER 7, 2022

Tackling Medicare Part D drug costs takes more than just capping costs.

307

307

PharmaVoice

NOVEMBER 7, 2022

A look at emerging treatments and where there’s hope for patients.

264

264

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

NOVEMBER 7, 2022

In a recent study, researchers found that text message reminders led to increased influenza vaccination rates, along with many receiving the vaccine sooner.

Vaccines 307

Vaccines 307

PhRMA

NOVEMBER 7, 2022

The United States is facing a crisis of mental health and addiction that has left few Americans and families unimpacted by these illnesses and the devastating consequences that are often associated with them. Mental illness refers to a wide range of mental health conditions that can affect mood, thinking and behavior. These illnesses include substance use disorders and such conditions as depression, anxiety disorders, schizophrenia, bipolar disorder and eating disorders.

250

250

PharmaVoice

NOVEMBER 7, 2022

Using flipMD, organizations can find, vet, connect with and source practicing board-certified physicians from all specialties for contract, project-based or full-time assignments.

246

246

Drug Topics

NOVEMBER 7, 2022

Drug Topics® is joined by Joseph Mann, MSN, FNP-C, to discuss the impact of the CDC's streamlined COVID-19 guidance on pharmacy, how pharmacists can prepare for testing demand during the winter respiratory season, and why taking a proactive approach is so important.

247

247

PharmaVoice

NOVEMBER 7, 2022

With control of the House and Senate both up for grabs, and potentially leaning Republican, here’s what the midterm elections mean for pharma.

246

246

Pharmacy Times

NOVEMBER 7, 2022

A session presenter at the ASCP 2022 Annual Meeting addresses research investigating the value of preventative treatments when patients have a limited life expectancy.

181

181

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

NOVEMBER 7, 2022

UnitedHealth continues to lead the way on insurer profits in Q3. Here's how its competitors fared. pminemyer. Mon, 11/07/2022 - 15:36.

Insurance 133

Insurance 133

Pharmacy Times

NOVEMBER 7, 2022

A session presenter at the ASCP 2022 Annual Meeting explained how the COVID-19 pandemic significantly magnified the importance of infection prevention and control practices in long-term care.

132

132

PharmaVoice

NOVEMBER 7, 2022

Using RWE alongside clinical trial data has the potential to streamline time-to-insight while generating a fuller and more patient-centric view of a given therapy’s efficacy.

130

130

Pharmacy Times

NOVEMBER 7, 2022

Leaders must fully understand the benefits of diversity and create an environment in which it thrives to cultivate and inspire the next generation of inclusive leaders.

132

132

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

NOVEMBER 7, 2022

Blood cells grown in a laboratory have been given to people for the first time in a clinical trial being carried out by researchers in the UK, in the hope that plentiful supplies of rare blood groups can be manufactured to order. A team from the universities of Bristol and Cambridge, NHS trusts and NHS Blood and Transplant (NHSBT) have started giving small quantities of the lab-grown red blood cells – a couple of teaspoons full – to two healthy volunteers to see if they are safe.

126

126

Pharmacy Times

NOVEMBER 7, 2022

A session presenter at the ASCP 2022 Annual Meeting explained how patients’ mismanagement of medications for headaches can lead to rebound headaches.

123

123

Fierce Healthcare

NOVEMBER 7, 2022

Walgreens' VillageMD inks $9B deal to buy Summit Health, marking largest physician deal of the year. hlandi. Mon, 11/07/2022 - 11:57.

122

122

Pharmacy Times

NOVEMBER 7, 2022

Session presenters at ASCP 2022 Annual Meeting discuss the benefits and disadvantages of apixaban versus warfarin for anticoagulation.

122

122

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

European Pharmaceutical Review

NOVEMBER 7, 2022

Lab-grown blood cells have been transfused into a second patient in the world’s first-of-a-kind clinical trial , opening up future treatments for blood disorders such as sickle cell if found safe and effective. Stem cells from blood donors were separated and grown to produce modified red blood cells at NHS Blood and Transplant ( NHSBT ) Advanced Therapies Unit in Bristol.

Hospitals 119

Hospitals 119

Fierce Healthcare

NOVEMBER 7, 2022

Fierce Healthcare Fundraising Tracker—DispatchHealth rakes in $330M; Care.ai banks $27M for ambient intelligence. hlandi. Mon, 11/07/2022 - 17:36.

116

116

STAT

NOVEMBER 7, 2022

The morning was crisp and still dark as I sat in my car in the hospital lot, summoning the will to open the door and leave for my shift in the emergency department. Like many frontline providers in early 2021, I felt pancaked by the two pandemic surges — emotionally and morally. Not getting out of the car wasn’t an option. Responsibility to others demanded I get moving.

Hospitals 108

Hospitals 108

Drug Store News

NOVEMBER 7, 2022

Amazon is beginning to offer its Amazon One palm payment shopping experience at more Whole Foods Market stores.

106

106

pharmaphorum

NOVEMBER 7, 2022

In this new segment from pharmaphorum, we collect the most significant hirings, firings, and recruitment stories from across the industry. This month, we highlight new appointments from Lumeris, Lineage Cell Therapeutics, 1910 Genetics, and ADC Therapeutics. . Ben Grabski, Lumeris. Lumeris, a value-based care managed services operator for health systems, has appointed Ben Grabski as chief financial officer.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

NOVEMBER 7, 2022

Pfizer Inc. has announced its B-cell maturation antigen (BCMA)-CD3-targeted bispecific antibody (BsAb) elranatamab for relapsed or refractory multiple myeloma (RRMM) has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA). The designation is based on six months of follow-up data from a Phase II study ( NCT04649359 ) evaluating the safety and efficacy of a 76mg weekly (QW) dose of elranatamab, which showed overall response rate (ORR) was 61 percent. .

FDA 105

FDA 105

STAT

NOVEMBER 7, 2022

TEMPE, AZ. — On a windy, warm November night, thousands of Arizona Democrats lined the perimeter of a Tempe high school, desperate to get into the school’s auditorium for a chance to see former President Barack Obama. They weren’t optimistic — about getting in, or the party’s chances in the midterms. At the last-minute rally with gubernatorial candidate Katie Hobbs and Sen.

104

104

The Guardian - Pharmaceutical Industry

NOVEMBER 7, 2022

Exclusive: MHRA grants innovation passport to drug that could prevent women from developing condition A new pill that could prevent pre-eclampsia has become the first pregnancy drug to be fast-tracked for development by the UK’s drug regulator. Scientists at MirZyme Therapeutics, a biopharmaceutical company, believe they have developed a drug that when given to women from 20 weeks of pregnancy could stop them developing the condition.

98

98

STAT

NOVEMBER 7, 2022

As Americans head to the polls, some candidates continue to deny the results of the 2020 presidential election – and several of the largest players in the pharmaceutical industry have contributed to their campaigns. Over the past year, the Pharmaceutical Research and Manufacturers of America, the industry trade group, donated more than $1.2 million to organizations which then funneled money toward Republicans who are running for various state offices and have denied the 2020 election resu

104

104

Outsourcing Pharma

NOVEMBER 7, 2022

Charles River Laboratoriesâ growing gene therapy manufacturing capabilities have landed it a deal with the eye disease biotech Nanoscope Therapeutics.

98

98

STAT

NOVEMBER 7, 2022

Biogen is mulling new options in its search for a CEO after talks with a senior research executive from Johnson & Johnson reached an impasse, STAT has learned. Mathai Mammen, a well-regarded scientist and head of R&D at pharmaceutical giant J&J, had been a frontrunner to become Biogen’s next leader as late as last month. But more recently, talks between Mammen and the company’s board broke down, according to a person familiar with the situation.

104

104

Pharmaceutical Technology

NOVEMBER 7, 2022

NKGen Biotech and the Parkinson’s Foundation have entered a partnership to progress the former’s new natural killer (NK) cell therapy development for advanced Parkinson’s disease (PD). The alliance will focus on measures to expedite the clinical programme of NKGen using its autologous NK cell therapy, SNK01, and leveraging its clinical partners and donors’ network.

Labelling 98

Labelling Patient Care FDA 98

STAT

NOVEMBER 7, 2022

Californians have an opportunity on Tuesday to protect the health of their children by voting yes on Proposition 31 , which would be a vote to prohibit the sale of nearly all flavored tobacco products in the state. It’s a much-needed move, and one that every state in the nation should be taking. Flavored e-cigarettes have addicted a new generation of Americans to nicotine.

98

98

Fierce Healthcare

NOVEMBER 7, 2022

What a divided Congress could mean for healthcare in the next year. rking. Mon, 11/07/2022 - 16:49.

98

98

STAT

NOVEMBER 7, 2022

In recent weeks, the National Institutes of Health has begun emailing academic institutions that failed to submit results of clinical trials to a government database, a move that comes shortly after a federal watchdog harshly criticized the agency for lax oversight. More than two dozen institutions have been contacted as of this week, according to the Clinical Trials Registration and Results Reporting Taskforce, a national consortium of academic medical centers, universities, hospitals, and nonp

Hospitals 98

Hospitals 98